{"id":"W4206933741","doi":"10.1093/ecco-jcc/jjab232.038","title":"OP39 Shorter disease duration is associated with better outcomes in patients with moderately to severely active Crohn’s Disease treated with risankizumab: Results from the phase 3 ADVANCE, MOTIVATE, and FORTIFY studies","year":2022,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Maintenance therapy; Internal medicine; Crohn's disease; Placebo; Clinical trial; Post-hoc analysis; Confidence interval; Post hoc; Induction therapy; Disease; Gastroenterology; Surgery; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002212279,0.0004763176,0.001050889,0.0002722091,0.0002373074,0.0009874579,0.0003377971,0.0005672805,0.002080935],"category_scores_gemma":[0.001901713,0.0001785924,0.00182383,0.0004850182,0.0003354406,0.000628191,0.0004914194,0.0009893775,0.0001893598],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002073838,"about_ca_system_score_gemma":0.0003484539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004044954,"about_ca_topic_score_gemma":0.001018077,"domain_scores_codex":[0.9992384,0.0003205831,0.00009100163,0.0001428809,0.0001248362,0.00008230152],"domain_scores_gemma":[0.9964551,0.0008962417,0.001558825,0.0002029483,0.0002448528,0.0006421527],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2595056,0.001544501,0.653046,0.001915149,0.01048625,0.000286391,0.0002254513,0.0004908609,0.007340449,0.0002005784,0.002673751,0.06228504],"study_design_scores_gemma":[0.008744547,0.01433247,0.9679375,0.0001945854,0.003748098,0.0003008232,0.0001319105,0.0004312432,0.0006546103,0.0002049135,0.003275929,0.00004338149],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875405,0.009938289,0.0001414126,0.0002446765,0.0000542653,0.0000603242,0.000947843,0.000007624948,0.001064916],"genre_scores_gemma":[0.9966186,0.001289729,0.0001603418,0.0002139326,0.0001469506,0.0000453777,0.001214423,0.000004163398,0.0003065632],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002212279,"threshold_uncertainty_score":0.01169986,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009207779496859568,"score_gpt":0.2495726513838618,"score_spread":0.2403648718870023,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}